DIA
ANAC

Denver Investment Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Denver Investment Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,597
Closed -$324K – 676
2015
Q1 		$324K Sell
5,597
-2,572
-31% -$109K 0.01% 460
2014
Q4 		$263K Sell
8,169
-3,016
-27% -$90.5K 0.01% 498
2014
Q3 		$274K Buy
11,185
+632
+6% +$12.8K 0.01% 454
2014
Q2 		$187K Buy
+10,553
New +$170K 0.01% 556

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Denver Investment Advisors's ANAC Position: Q2 2015 in Review

Denver Investment Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2015, closing a stake of 5,597 shares — an estimated $324K sold.

Denver Investment Advisors first reported a position in ANAC in Q2 2014 and held it in 4 quarters. The position peaked at $324K in Q1 2015. 177 funds tracked by Wall St. Rank hold ANAC as of Q2 2015.

  • Denver Investment Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 5,597 ANACOR PHARMACEUTICALS INC COM shares in Q2 2015, an estimated $324K.
  • Denver Investment Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 4 quarters.
  • Denver Investment Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $324K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2015.

Based on Denver Investment Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.